Free Trial

TherapeuticsMD (TXMD) SEC Filings & 10K Form

TherapeuticsMD logo
$1.12 -0.02 (-1.75%)
(As of 10:50 AM ET)

Recent TherapeuticsMD SEC Filings

DateFilerForm TypeView
12/05/2024
4:15 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
4:00 PM
TherapeuticsMD (Filer)
Form DEF 14A
10/25/2024
4:01 PM
TherapeuticsMD (Filer)
Form DEFA14A
10/25/2024
4:02 PM
TherapeuticsMD (Filer)
Form ARS
09/20/2024
4:00 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2024
4:40 PM
Collins Cooper C. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
5:18 PM
Collins Cooper C. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:16 PM
TherapeuticsMD (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2024
3:10 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:29 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
3:32 PM
TherapeuticsMD (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TXMD) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners